Insider · CIK 0001403322

Malley Thomas

Reports to the SEC for 7 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001403322

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+35K sh	—	—	35,000
2026-05-29	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+2,799 sh	—	—	15,345
2026-05-29	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,799 sh	—	—	0
2026-05-29	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+2,026 sh	—	—	2,026
2026-05-29	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+12.2K sh	—	—	12,158
2026-03-18	KURAKura Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.12	+$31.2K	10,000
2026-03-18	KURAKura Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	—	—	0
2025-08-14	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+26.2K sh	$15.19	+$399K	90,779
2025-08-14	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+33.2K sh	$14.33	+$476K	64,543
2025-08-14	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+18.8K sh	$15.47	+$290K	31,306
2025-08-14	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−33.2K sh	—	—	0
2025-08-14	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−18.8K sh	—	—	0
2025-08-14	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−78.2K sh	$33.09	−$2.59M	12,546
2025-08-14	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−26.2K sh	—	—	0
2025-08-13	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−20.1K sh	—	—	0
2025-08-13	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2025-08-13	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+20.1K sh	$10.36	+$209K	32,675
2025-08-13	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$9.88	+$296K	62,675
2025-08-13	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−50.1K sh	$33.32	−$1.67M	12,546
2025-08-12	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−27.4K sh	—	—	0
2025-08-12	KNSAKiniksa Pharmaceuticals International, plcS Sale	Director	SSale	−49.4K sh	$32.40	−$1.6M	12,546
2025-08-12	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+22K sh	$1.86	+$40.8K	34,505
2025-08-12	KNSAKiniksa Pharmaceuticals International, plc · Share OptionM Exercise/Conversion	Director	MExercise/Conversion	−22K sh	—	—	0
2025-08-12	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+27.4K sh	$3.80	+$104K	61,953
2025-06-05	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,173 sh	—	—	0
2025-06-05	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+3,173 sh	—	—	12,546
2025-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+28.5K sh	—	—	28,500
2025-06-03	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+16.8K sh	—	—	16,798
2025-06-03	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+2,799 sh	—	—	2,799
2024-06-06	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+4,373 sh	—	—	9,373
2024-06-06	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,373 sh	—	—	0
2024-06-05	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+19K sh	—	—	19,040
2024-06-05	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+3,173 sh	—	—	3,173
2024-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+26K sh	—	—	26,000
2023-06-29	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2023-06-29	KNSAKiniksa Pharmaceuticals International, plcM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	—	—	5,000
2023-06-16	KURAKura Oncology, Inc.P Purchase	Director	PPurchase	+50K sh	$11.50	+$575K	139,557
2023-06-15	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	26,975
2023-06-15	ONCBeOne Medicines Ltd.A Award	Director	AAward	+12.9K sh	—	—	46,696
2023-06-06	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+4,373 sh	—	—	4,373
2023-06-06	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+26.2K sh	—	—	26,236
2023-05-31	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+26K sh	—	—	26,000
2022-06-29	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+30K sh	—	—	30,000
2022-06-29	KNSAKiniksa Pharmaceuticals International, plc · Restricted Share UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2022-06-22	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+34.6K sh	—	—	34,645
2022-06-22	ONCBeOne Medicines Ltd.A Award	Director	AAward	+16.7K sh	—	—	33,774
2022-06-21	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+23K sh	—	—	23,000
2021-06-29	KNSAKiniksa Pharmaceuticals International, plc · Share OptionA Award	Director	AAward	+33.2K sh	—	—	33,237
2021-06-22	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+23K sh	—	—	23,000
2021-06-16	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,498

Recent filings

Accepted (ET)
Jun 44
Malley Thomas0001193125-26-257896
SEC(opens sec.gov)
Jun 24
Malley Thomas0001403322-26-000002
SEC(opens sec.gov)
Mar 204
Malley Thomas0001193125-26-116834
SEC(opens sec.gov)
Aug 144
Malley Thomas0001415889-25-021941
SEC(opens sec.gov)

Companies

Address

C/O KURA ONCOLOGY, INC. 4930 DIRECTORS PLACE, SUITE 500

SAN DIEGO, CA, 92121